In this analysis, age, smoking status, history of previous thromboembolism, BMI, atrial fibrillation, metabolic dysfunction-associated fatty liver disease, type 2 diabetes, metabolic syndrome, arterial hypertension and dyslipidemia, serum creatinine, eGFR, total bilirubin, total plasma proteins, and alanine aminotransferase levels were considered as variables. The gene discussed is GPT; the disease is fatty liver disease.